RANKL/RANK Pathway Abrogates Cetuximab Sensitivity in Gastric Cancer Cells via Activation of EGFR and c-Src [Corrigendum]
Authors:
- Xiaomeng ZhangXZXiaomeng Zhang
- Yongxi SongYSYongxi Song
- Na SongNSNa Song
- Ye ZhangYZYe Zhang
- Lingyun ZhangLZLingyun Zhang
- Yan WangYWYan Wang
- Zhenning WangZWZhenning Wang
- Xiujuan QuXQXiujuan Qu
- Yunpeng LiuYLYunpeng Liu
Open Access
- 13 May 2022
- journal article
- correction
- Published by Taylor & Francis in OncoTargets and Therapy
- Vol. ume 15, 529-530